Skip to main content
Martin Matzuk, MD, Pathology, Houston, TX

Martin M Matzuk MD Ph.D.

Chemical Pathology, Clinical Pathology


Chair and Professor, Department of Pathology & Immunology, Baylor College of Medicine

Join to View Full Profile
  • 1504 Taub LoopHouston, TX 77030

  • Phone+1 713-873-3200

  • Fax+1 713-873-3214

Dr. Matzuk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Martin Matzuk is Chair of the Department of Pathology & Immunology at Baylor College of Medicine in Houston, Texas, and is affiliated with multiple hospitals in the area, including Ben Taub Hospital (Harris Health System) and Baylor St. Luke's Medical Center. He received his M.D. and Ph.D. degrees from Washington University School of Medicine and has been in practice 28 years. He specializes in clinical pathology (clinical chemistry).

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineResidency, Pathology-Anatomic and Clinical, 1991 - 1993
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1990 - 1991
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1989

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1993 - 2027
  • AZ State Medical License
    AZ State Medical License 1993 - 1994

Publications & Presentations

PubMed

Journal Articles

  • The TGF-Β Family in the Reproductive Tract  
    Martin Matzuk, MD, Genes & Development

Press Mentions

  • A Faster, Less Expensive Approach Identifies Highly Specific Anti-Cancer Compounds
    A Faster, Less Expensive Approach Identifies Highly Specific Anti-Cancer CompoundsJune 7th, 2022
  • Novel Approach Identifies Highly Specific Anti-Cancer Compounds
    Novel Approach Identifies Highly Specific Anti-Cancer CompoundsJune 3rd, 2022
  • New Screening Method Identifies COVID-19 Protein Inhibitor
    New Screening Method Identifies COVID-19 Protein InhibitorSeptember 3rd, 2021
  • Join now to see all

Grant Support

  • Reversible male contraception by inhibition of serine/threonine kinase 33BAYLOR COLLEGE OF MEDICINE2024–2029
  • Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptiveUNIVERSITY OF MISSOURI-COLUMBIA2022–2027
  • Kinases as Therapeutic Targets for EndometriosisBAYLOR COLLEGE OF MEDICINE2022–2027
  • Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptiveUNIVERSITY OF MISSOURI-COLUMBIA2022–2027
  • Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptiveUNIVERSITY OF MISSOURI-COLUMBIA2022–2027
  • Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptiveUNIVERSITY OF MISSOURI-COLUMBIA2022–2027
  • Functional analysis of novel testis-expressed secreted and transmembrane proteinsBAYLOR COLLEGE OF MEDICINE2016–2027
  • Transforming growth factor β family signaling pathways in ovarian and uterine biologyBAYLOR COLLEGE OF MEDICINE1994–2025
  • Transforming growth factor β family signaling pathways in ovarian and uterine biologyBAYLOR COLLEGE OF MEDICINE1994–2025
  • Project 3 - Micrornas In Endometrial Function And DysfunctionEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2012
  • Identification Of Small Molecule Contraceptives That Target The MALE GermlineEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2012
  • Analysis Of Reproductive Function Using Transgenic MiceEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
  • Defining The Mammalian Intercellular Bridge InteractomeEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2010
  • Zona Pellucida Binding Proteins In Sperm-Egg InteractionsEunice Kennedy Shriver National Institute Of Child Health &Human Development2006–2010
  • Analysis Of Reproductive Function Using Transgenic MiceEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2010
  • Mouse Models To Study Gonadal Tumor DevelopmentNational Cancer Institute1997–2010
  • Oogenesis, Spematogenesis And Sperm -Egg InteractionsEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2008
  • Regulation Of Key Processes In Oocyte BiologyEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2007
  • Division Of Biologic, Basis Of DiseaseCenter For Scientific Review2004–2005
  • Transgenic Mouse Models To Study Ovarian FunctionEunice Kennedy Shriver National Institute Of Child Health &Human Development1998–2002
  • Identification And Analysis Of Novel Ovarian GenesEunice Kennedy Shriver National Institute Of Child Health &Human Development1999–2000
  • Reproductive Function Using Transgenic MiceEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–2000
  • Mouse Models Of Ovarian Tumor DevelopmentNational Cancer Institute1993–1996
  • Developmental &Functional Roles Of Activin &InhibinEunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1993

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: